Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis

AIMS: Myocardial fibrosis alters the cardiac architecture favouring the development of cardiac dysfunction, including arrhythmias and heart failure. Reducing myocardial fibrosis may improve outcomes through the targeted diagnosis and treatment of emerging fibrotic pathways. The European‐Commission‐f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, João Pedro, Machu, Jean‐Loup, Girerd, Nicolas, Jaisser, Frederic, Thum, Thomas, Butler, Javed, González, Arantxa, Diez, Javier, Heymans, Stephane, McDonald, Kenneth, Gyöngyösi, Mariann, Firat, Hueseyin, Rossignol, Patrick, Pizard, Anne, Zannad, Faiez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793978/
https://www.ncbi.nlm.nih.gov/pubmed/28988439
http://dx.doi.org/10.1002/ehf2.12218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793978/
https://www.ncbi.nlm.nih.gov/pubmed/28988439
http://dx.doi.org/10.1002/ehf2.12218

Ejemplares similares